Altimmune Explores Obesity Drug Pemvidutide for Alcohol Use Disorder Treatment
2025-03-13Reuters
Altimmune announces plans to investigate its lead obesity treatment, pemvidutide, for potential use in treating alcohol use disorder and associated liver disease, offering new hope for those struggling with addiction and related health issues. This i ...Read more
